Sulphonamides Market

Sulphonamides Market

Sulphonamides Market Forecasts to 2030 - Global Analysis By Type (Sulfamethoxazole, Sulfadiazine, Sulfacetamide, Sulfasalazine, Sulfadoxine and Other Types), Formulation, Route of Administration, Application, End User and By Geography

4.7 (39 reviews)
4.7 (39 reviews)
Published: 2024 ID: SMRC25116

This report covers the impact of COVID-19 on this global market

Years Covered


Estimated Year Value (2023)

US $115.21 MN

Projected Year Value (2030)

US $186.21 MN

CAGR (2023 - 2030)


Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific

According to Stratistics MRC, the Global Sulphonamides Market is accounted for $115.21 million in 2023 and is expected to reach $186.21 million by 2030 growing at a CAGR of 7.1% during the forecast period. Sulphonamides are a class of synthetic antimicrobial drugs commonly used to treat bacterial infections. Acting as competitive inhibitors of folic acid synthesis in bacteria, they hinder essential metabolic processes, suppressing bacterial growth. Systemic sulphonamides are administered orally or parenterally for widespread infections, while topical formulations address localized issues. Their versatility extends to applications in both human and veterinary medicine.

According to NCBI, over 14 million cases of cellulitis are reported each year in the U.S., making it one of the most frequent bacterial skin infections. It is responsible for 650,000 hospital admissions per year and ambulatory care expenses of about USD 3.7 billion.

Market Dynamics: 


Increasing prevalence of infectious diseases

The mounting incidence of infectious diseases globally enhances the need for sulphonamides since these antimicrobial medicines successfully treat bacterial infections. Given the pressing need for efficient therapies against a variety of bacterial diseases, the pharmaceutical industry expects to see an increase in the use of these medications. This trend is particularly pronounced in regions with expanding populations and improving healthcare infrastructures, reinforcing sulphonamides' role in addressing the persistent challenge of infectious diseases on a broader scale.


Rising concerns about side effects

Concerns regarding possible side effects like rashes and allergic reactions are voiced by both patients and medical professionals, which hinders the drug's general uptake. Patients and healthcare professionals express apprehensions about potential adverse events, impacting the drug's overall adoption. The perceived risk of side effects can lead to a decline in patient compliance and reluctance among physicians to prescribe sulphonamides. This apprehension may divert preference towards alternative antibiotics or treatment options, hindering the market growth.


Growing population and healthcare infrastructure

With a growing populace, the incidence of bacterial infections rises, fostering increased demand for effective treatments. Improved healthcare facilities, especially in developing regions, enhance access to sulphonamides, amplifying their usage. The strengthened healthcare infrastructure facilitates better diagnosis and treatment, promoting the adoption of sulphonamides in managing various infectious diseases. This dynamic synergy between population growth and enhanced healthcare capabilities positions sulphonamides as essential components in addressing the escalating healthcare needs of burgeoning societies.


Limited spectrum of activity

In scenarios requiring broad-spectrum coverage, alternative antibiotics are the most favoured. Physicians, aiming for comprehensive treatments, may opt for antibiotics with a broader range of activity. The constrained scope of sulphonamides may result in their exclusion from treatment regimens, limiting their application and market share. This limitation hinders the versatility of sulphonamides, posing a challenge in situations where a more expansive antibacterial spectrum is deemed crucial for effective therapeutic interventions.

Covid-19 Impact

The covid-19 pandemic has influenced the sulphonamides market by disrupting supply chains, causing fluctuations in demand for antimicrobial agents. Healthcare priorities shifted towards managing the pandemic, impacting routine treatments. Disruptions in manufacturing and distribution channels, along with economic uncertainties, further affected the sulphonamides market. However, the essential nature of some sulphonamides in treating bacterial infections likely sustained demand, with the market adapting to ongoing challenges in the broader context of the global healthcare landscape.

The tablets segment is expected to be the largest during the forecast period

The tablets segment is estimated to have a lucrative growth. Sulphonamides tablets, a class of antimicrobial drugs, play a crucial role in treating bacterial infections. These tablets contain sulfa-based compounds that inhibit bacterial growth by interfering with folate synthesis. Commonly prescribed for urinary tract infections, respiratory tract infections, and other bacterial ailments, sulphonamide tablets offer a targeted therapeutic approach. Ongoing research aims to enhance formulations and overcome limitations, ensuring sulphonamide tablets continue to be effective and relevant in addressing a range of bacterial infections.

The antibacterial segment is expected to have the highest CAGR during the forecast period

The antibacterial segment is anticipated to witness the highest CAGR growth during the forecast period. Sulphonamides, as antibacterial agents, play a crucial role in combating bacterial infections. Widely utilized for their bacteriostatic properties, sulphonamides inhibit bacterial folate synthesis, impeding DNA and RNA production. This makes them effective against a range of bacterial pathogens. Their antibacterial application extends to respiratory, urinary, and skin infections. Sulphonamides continue to be pivotal in antibacterial therapeutics, contributing significantly to the global arsenal against bacterial diseases.

Region with largest share:

North America is projected to have the highest share over the forecast period, owing to its advanced healthcare infrastructure, robust research and development initiatives, and a high prevalence of infectious diseases. The region's well-established pharmaceutical sector fosters innovation in sulphonamide formulations. Further, North America remains a prominent market, with pharmaceutical advancements and a proactive approach toward infectious disease management fueling its continued prominence.

Region with highest CAGR:

The sulphonamides market in Asia Pacific is experiencing notable growth due to factors such as increasing healthcare infrastructure, rising prevalence of infectious diseases, and a burgeoning population. The region's expanding pharmaceutical industry, coupled with government initiatives to combat infections, propels market demand. With a focus on improving healthcare accessibility, countries in Asia Pacific are witnessing higher adoption of sulphonamides for treating bacterial infections. Additionally, ongoing research and development activities contribute to the market's dynamism, positioning Asia Pacific as a key player in the sulphonamides market.

Key players in the market

Some of the key players profiled in the Sulphonamides Market include Viatris Inc, Pfizer Inc, AA Pharma Inc, GlaxoSmithKline PLC, Azurity Pharmaceuticals, Teva Pharmaceutical Industries Limited, Valeo Pharma, Novartis Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Akorn Operating Company LLC, Sanofi S.A., Roche Holding AG, Merck & Co., Bayer AG, Johnson & Johnson, Abbott Laboratories, Bristol Myers Squibb Company, Eli Lilly and Company, AstraZeneca PLC and Boehringer Ingelheim International GmbH.

Key Developments:

In August 2022, Valeo Pharma Inc. and Novartis Pharmaceuticals Canada Inc., a subsidiary of Novartis AG, signed a supply and distribution agreement for SIMBRINZA in Canada. Brinzolamide is a carbonic anhydrase inhibitor and sulfonamide with a specific affinity for carbonic anhydrase II. This move ensured a broader reach of its products in the global market.

In July 2022, Azurity Pharmaceuticals Inc. received approval from the US FDA for ZONISADE (zonisamide oral suspension). Zonisamide is a sulfonamide antiepileptic drug.

Types Covered:
• Sulfamethoxazole
• Sulfadiazine
• Sulfacetamide
• Sulfasalazine
• Sulfadoxine
• Other Types

Formulations Covered:
• Tablets
• Liquid
• Powder
• Other Formulations

Route of Administrations Covered:
• Oral
• Parenteral
• Topical

Applications Covered:
• Antibacterial
• Antifungal
• Antimalarial
• Diuretic
• Antiviral
• Other Applications

End Users Covered:
• Pharmaceuticals
• Veterinary Medicine
• Agriculture
• Cosmetics
• Food & Beverage
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary   
2 Preface    
 2.1 Abstract   
 2.2 Stake Holders  
 2.3 Research Scope  
 2.4 Research Methodology 
  2.4.1 Data Mining 
  2.4.2 Data Analysis 
  2.4.3 Data Validation 
  2.4.4 Research Approach 
 2.5 Research Sources  
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions 
3 Market Trend Analysis  
 3.1 Introduction  
 3.2 Drivers   
 3.3 Restraints  
 3.4 Opportunities  
 3.5 Threats   
 3.6 Application Analysis 
 3.7 End User Analysis  
 3.8 Emerging Markets  
 3.9 Impact of Covid-19  
4 Porters Five Force Analysis  
 4.1 Bargaining power of suppliers 
 4.2 Bargaining power of buyers 
 4.3 Threat of substitutes 
 4.4 Threat of new entrants 
 4.5 Competitive rivalry  
5 Global Sulphonamides Market, By Type 
 5.1 Introduction  
 5.2 Sulfamethoxazole  
 5.3 Sulfadiazine  
 5.4 Sulfacetamide  
 5.5 Sulfasalazine  
 5.6 Sulfadoxine  
 5.7 Other Types  
6 Global Sulphonamides Market, By Formulation
 6.1 Introduction  
 6.2 Tablets   
 6.3 Liquid   
 6.4 Powder   
 6.5 Other Formulations  
7 Global Sulphonamides Market, By Route of Administration
 7.1 Introduction  
 7.2 Oral   
 7.3 Parenteral  
 7.4 Topical   
8 Global Sulphonamides Market, By Application
 8.1 Introduction  
 8.2 Antibacterial  
 8.3 Antifungal  
 8.4 Antimalarial  
 8.5 Diuretic   
 8.6 Antiviral   
 8.7 Other Applications  
9 Global Sulphonamides Market, By End User
 9.1 Introduction  
 9.2 Pharmaceuticals  
 9.3 Veterinary Medicine 
 9.4 Agriculture  
 9.5 Cosmetics  
 9.6 Food & Beverage  
 9.7 Other End Users  
10 Global Sulphonamides Market, By Geography
 10.1 Introduction  
 10.2 North America  
  10.2.1 US  
  10.2.2 Canada  
  10.2.3 Mexico  
 10.3 Europe   
  10.3.1 Germany  
  10.3.2 UK  
  10.3.3 Italy  
  10.3.4 France  
  10.3.5 Spain  
  10.3.6 Rest of Europe 
 10.4 Asia Pacific  
  10.4.1 Japan  
  10.4.2 China  
  10.4.3 India  
  10.4.4 Australia  
  10.4.5 New Zealand 
  10.4.6 South Korea 
  10.4.7 Rest of Asia Pacific 
 10.5 South America  
  10.5.1 Argentina 
  10.5.2 Brazil  
  10.5.3 Chile  
  10.5.4 Rest of South America
 10.6 Middle East & Africa 
  10.6.1 Saudi Arabia 
  10.6.2 UAE  
  10.6.3 Qatar  
  10.6.4 South Africa 
  10.6.5 Rest of Middle East & Africa
11 Key Developments   
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
 11.2 Acquisitions & Mergers 
 11.3 New Product Launch 
 11.4 Expansions  
 11.5 Other Key Strategies 
12 Company Profiling   
 12.1 Viatris Inc  
 12.2 Pfizer Inc   
 12.3 AA Pharma Inc  
 12.4 GlaxoSmithKline PLC 
 12.5 Azurity Pharmaceuticals 
 12.6 Teva Pharmaceutical Industries Limited
 12.7 Valeo Pharma  
 12.8 Novartis Pharmaceuticals 
 12.9 Sun Pharmaceutical Industries Ltd
 12.10 Akorn Operating Company LLC 
 12.11 Sanofi S.A.  
 12.12 Roche Holding AG  
 12.13 Merck & Co.  
 12.14 Bayer AG   
 12.15 Johnson & Johnson  
 12.16 Abbott Laboratories  
 12.17 Bristol Myers Squibb Company
 12.18 Eli Lilly and Company 
 12.19 AstraZeneca PLC  
 12.20 Boehringer Ingelheim International GmbH
List of Tables    
1 Global Sulphonamides Market Outlook, By Region (2021-2030) ($MN)
2 Global Sulphonamides Market Outlook, By Type (2021-2030) ($MN)
3 Global Sulphonamides Market Outlook, By Sulfamethoxazole (2021-2030) ($MN)
4 Global Sulphonamides Market Outlook, By Sulfadiazine (2021-2030) ($MN)
5 Global Sulphonamides Market Outlook, By Sulfacetamide (2021-2030) ($MN)
6 Global Sulphonamides Market Outlook, By Sulfasalazine (2021-2030) ($MN)
7 Global Sulphonamides Market Outlook, By Sulfadoxine (2021-2030) ($MN)
8 Global Sulphonamides Market Outlook, By Other Types (2021-2030) ($MN)
9 Global Sulphonamides Market Outlook, By Formulation (2021-2030) ($MN)
10 Global Sulphonamides Market Outlook, By Tablets (2021-2030) ($MN)
11 Global Sulphonamides Market Outlook, By Liquid (2021-2030) ($MN)
12 Global Sulphonamides Market Outlook, By Powder (2021-2030) ($MN)
13 Global Sulphonamides Market Outlook, By Other Formulations (2021-2030) ($MN)
14 Global Sulphonamides Market Outlook, By Route of Administration (2021-2030) ($MN)
15 Global Sulphonamides Market Outlook, By Oral (2021-2030) ($MN)
16 Global Sulphonamides Market Outlook, By Parenteral (2021-2030) ($MN)
17 Global Sulphonamides Market Outlook, By Topical (2021-2030) ($MN)
18 Global Sulphonamides Market Outlook, By Application (2021-2030) ($MN)
19 Global Sulphonamides Market Outlook, By Antibacterial (2021-2030) ($MN)
20 Global Sulphonamides Market Outlook, By Antifungal (2021-2030) ($MN)
21 Global Sulphonamides Market Outlook, By Antimalarial (2021-2030) ($MN)
22 Global Sulphonamides Market Outlook, By Diuretic (2021-2030) ($MN)
23 Global Sulphonamides Market Outlook, By Antiviral (2021-2030) ($MN)
24 Global Sulphonamides Market Outlook, By Other Applications (2021-2030) ($MN)
25 Global Sulphonamides Market Outlook, By End User (2021-2030) ($MN)
26 Global Sulphonamides Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
27 Global Sulphonamides Market Outlook, By Veterinary Medicine (2021-2030) ($MN)
28 Global Sulphonamides Market Outlook, By Agriculture (2021-2030) ($MN)
29 Global Sulphonamides Market Outlook, By Cosmetics (2021-2030) ($MN)
30 Global Sulphonamides Market Outlook, By Food & Beverage (2021-2030) ($MN)
31 Global Sulphonamides Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.